Representative Warrants. The Representative Warrants shall have the same terms and be in the same form as the Public Warrants.
Representative Warrants. Subject to Section 6.4, the Representative Warrants shall have the same terms, and be in the same form, as the Public Warrants.
Representative Warrants. The warrants underlying the unit purchase options issued to the Representative or its designees (the “Representative Warrants”) shall have the same terms and be in the same form as the Public Warrants.
Representative Warrants. The Company hereby agrees to issue to the Representative (and/or its designees) on the Closing Date warrants (“Representative Warrants”) to purchase such number of Ordinary Shares, representing six percent (6%) of the total number of Offered Securities. The agreement(s) representing the Representative Warrants, in the form attached hereto as Exhibit B (the “Representative’s Warrant Agreement”), shall be exercisable at any time, and from time to time, in whole or in part, commencing from the date of issuance and expiring on the fifth year anniversary of the commencement of sales of the Offering at an initial exercise price per share of $[●], which is equal to 125% of the offering price of the Firm Shares. The Representative’s Warrant Agreement and the Ordinary Shares issuable upon exercise thereof (the “Warrant Shares”) are hereinafter referred to together as the “Representative’s Securities.” The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative’s Warrants and the Warrant Shares during the one hundred eighty (180) days beginning on the date of commencement of sales of the Offering and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Representative’s Warrants, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days beginning on the date of commencement of sales of the Offering to anyone other than (i) an Underwriter or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Representative or of any such Underwriter or selected dealer; and only if any such transferee agrees to the foregoing lock-up restrictions.
Representative Warrants. Subject to compliance with FINRA Rule 5110, the Representative Warrants shall have the same terms and be in the same form as the Public Warrants.
Representative Warrants. On the Closing Date and if any, each Option Closing Date, the Company shall issue to the Representative warrants to purchase a number of Ordinary Shares equal to seven percent (7%) of the aggregate number of Ordinary Shares sold in the Offering by the Underwriters (the “Representative Warrants”). The Representative Warrants, in the form attached hereto as Exhibit B, shall be exercisable at 110% of the public offering price. The Representative Warrants and the underlying Units issuable upon exercise shall be subject to a lock-up restriction pursuant to the rules of FINRA and in particular FINRA Rule 5110(g)(1), for a period of 180 days immediately following the Effective Date, and expire five (5) years from the Effective Date. The Representative Warrants shall include a “net issuance” or “cashless” exercise feature.
Representative Warrants. The Company shall issue to Xxxxxx Xxxxxx & Co., LLC or its designees on each of the Closing Date and each Option Closing Date, warrants (the “Representative Warrants”) to purchase that number of Common Shares equal to five percent (5%) of the aggregate number of Common Shares issued on each of the Closing Date and each Option Closing Date. The Representative Warrants shall be in a customary form reasonably acceptable to the Underwriter and the Company, shall be exercisable, in whole or in part, immediately and shall expire on the five-year anniversary of the date of commencement of sales of the Firm Securities pursuant to the Registration Statement at an initial exercise price per Common Share equal to 125% of the price per Firm Share set forth in paragraph one hereof. The Representative Warrants shall be subject to the limitation on exercise set forth in FINRA Rule 5110(g)(8); provided, however, that pursuant to FINRA Rule 5110(e)(1) the Representative Warrants shall not be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days commencing on the date of sales of the Firm Securities, consistent with FINRA Rule 5110(e)(1), except for the transfers enumerated in FINRA Rule 5110(e)(2). The Representative Warrants and the Common Shares issuable upon exercise of the Representative Warrants are hereinafter referred to collectively as the “Representative's Securities.” The form of the Representative Warrant is attached hereto as Exhibit 1.
Representative Warrants. The Representative shall have received electronic copies of the Representative Warrants at least one (1) full business day prior to the Closing Date.
Representative Warrants. The Representative Warrants, when issued, shall have the same terms and be in the same form as the Public Warrants. The provisions of this Section 2.7 may not be modified, amended or deleted without the prior written consent of the Representative.
Representative Warrants. The Company hereby agrees to issue to the Representative (and/or its designees) (i) on the First Closing Date, warrants to purchase such number of shares of Common Stock equal to 8% of the Firm Shares issued at such Closing and (ii) on the Second Closing Date, as applicable, warrants to purchase such number of shares of Common Stock equal to 8% of the Option Shares issued at such closing (collectively, the “Representative Warrants”). The Representative Warrants shall be substantially in the form filed as an exhibit to the Registration Statement (as defined below), which shall be registered in the name or names and shall be in such denominations as the Representative may request (subject to compliance with the applicable FINRA rules (as defined below)) at least one (1) Business Day before each applicable Closing Date.
